NFKB1 and nasopharyngeal carcinoma: This is apparent in EBV(+) NPC, as both high rates of NF-κB pathway mutations and LPM1 overexpression (which also drives NF-κB activation) are found to be existing in mutually exclusive subsets of NPC tumors, totally more than 70% of all NPC cases.